No recommendation, just a comment my nationally-prominent MO (a name many here might recognize) made when I was wanting to quit at 2 years. Keep in mind this was in mid 2015, and some studies have been published since then. Notably, a Dr. Nabid has done a lot on the topic, so his work may be good enough to trust. Others can comment on that. Here's one of his recent items, take it for what it's worth. Looks pretty encouraging though:ADT+RT duration can safely be shortened in high risk PC
She said, "I'd rather find out 10 years from now that 3 years was too much, rather than that 2 years wasn't enough." She also pointed out that there is a lot of discussion about
HT duration in breast cancer. But, they're debating how much longer
to continue it!
I'm not sure if HT is worse for men than for women. It really devastates who and what we are as men, though. I didn't like it, won't like it if I have to do it again. My G9 is a worst case scenario, and most likely to benefit from longer ADT.
Still, to this day, the point is argued by many.
Bx: 6/12 pos, G9=5+4 (80%, 60%), 4+5 (2@100%, 80%, 10%), PNI+
cT3a (3T mpMRI: Bilateral EPE, NVB+, SV-, LN-)
Date PSA fPSA
9/12 4.1 15%
3/13 5.2 12% PCA3=31
IGRT by IMRT, 44 done 8/28/13: 50.4 Gy pelvic nodes, 79.2 Gy prostate
ADT2 3 yrs: Lupron/Casodex, ended 3/16
PSA <0.1 : 8/13 - 5/16;
rising - 0.2-8/16, 0.5-12/16, 0.7-3/17, 0.8-5/17, 0.8-7/17
Post Edited (Redwing57) : 8/27/2017 12:26:01 PM (GMT-6)